GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka DD (WAR:KRK) » Definitions » EV-to-FCF

Krka DD (WAR:KRK) EV-to-FCF : 17.98 (As of Dec. 14, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Krka DD EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Krka DD's Enterprise Value is zł15,977 Mil. Krka DD's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was zł889 Mil. Therefore, Krka DD's EV-to-FCF for today is 17.98.

The historical rank and industry rank for Krka DD's EV-to-FCF or its related term are showing as below:

WAR:KRK' s EV-to-FCF Range Over the Past 10 Years
Min: -1404.54   Med: 10.34   Max: 54.51
Current: 18.66

During the past 13 years, the highest EV-to-FCF of Krka DD was 54.51. The lowest was -1404.54. And the median was 10.34.

WAR:KRK's EV-to-FCF is ranked better than
62% of 550 companies
in the Drug Manufacturers industry
Industry Median: 25.795 vs WAR:KRK: 18.66

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), Krka DD's stock price is zł602.00. Krka DD's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was zł51.558. Therefore, Krka DD's PE Ratio (TTM) for today is 11.68.


Krka DD EV-to-FCF Historical Data

The historical data trend for Krka DD's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka DD EV-to-FCF Chart

Krka DD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.82 9.12 11.10 6.21 32.91

Krka DD Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.09 32.91 27.65 20.34 18.14

Competitive Comparison of Krka DD's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Krka DD's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka DD's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka DD's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Krka DD's EV-to-FCF falls into.



Krka DD EV-to-FCF Calculation

Krka DD's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=15977.351/888.585
=17.98

Krka DD's current Enterprise Value is zł15,977 Mil.
Krka DD's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł889 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krka DD  (WAR:KRK) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Krka DD's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=602.00/51.558
=11.68

Krka DD's share price for today is zł602.00.
Krka DD's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł51.558.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Krka DD EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Krka DD's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Krka DD Business Description

Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of its revenue from the European Union.

Krka DD Headlines

No Headlines